Product
Ceftazidime-avibactam
3 clinical trials
3 indications
Indication
Gram-negative InfectionsIndication
SepsisClinical trial
Retrospective Analysis to Characterize the Real World Use Patterns, Efficacy and Safety of Ceftazidime-avibactam in the Management of Gram Negative Infections.Status: Completed, Estimated PCD: 2022-03-11
Clinical trial
Clinical Study on Monitoring the Plasma Concentration of Ceftazidime-Avibactam in Critically Ill PatientsStatus: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
Ceftazidime-Avibactam Versus Colistin in Critically Ill Patients With Carbapenem-Resistant Enterobacteriaceae Infections (AVI-ICU): A Non-Inferiority Randomized Clinical TrialStatus: Terminated, Estimated PCD: 2023-04-12